Offering the nation's most advanced brain tumor treatments
The Hermelin Brain Tumor Center at Henry Ford Hospital, founded in honor of David Hermelin - former U.S. Ambassador to Norway and a brain tumor patient at Henry Ford - has become a national leader in brain tumor treatment by making surgery safer and recovery faster, by creating new delivery methods for life-saving drugs and by conducting ongoing research.
In 1993, Henry Ford became the first site in Michigan and one of only nine medical institutions in the country to be selected as part of a National Cancer Institute funded brain tumor consortium. Known as the New Approaches to Brain Tumor Therapy (NABTT) consortium, the Hermelin Brain Tumor Center team works with Johns Hopkins, Massachusetts General and other world renown brain cancer programs to develop and deliver novel treatments for brain tumor patients.
Each year, our specialists treat approximately 400 neuro-oncology cases, perform more than 250 brain tumor surgeries, 60 radiosurgeries and more than 120 radiation treatments for brain tumors.
Patients and their referring physicians also can count on our response time. The brain tumor team at Henry Ford Hospital aims to see patients within 24 hours of referral. Patients will be met with the highest standard of care that includes:
For more information about our unique and highly-effective treatment program, visit the pages of our website to learn about our team, approach, new treatments and much more.
